Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Mobia Medical, Inc.MOBI · Entity 5669 | Director · 10% owner | January 30, 2026 | May 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Mobia Medical, Inc.
Report date January 30, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 284,324 |
Reported balance
After 2026-05-11 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-05-11 · Conversion · Acquired 284,324 · Balance 284,324 F1: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 264,746 |
Reported balance
After 2026-05-11 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-05-11 · Conversion · Acquired 264,746 · Balance 264,746 F1: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F3: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 1,740,050 |
Reported balance
After 2026-05-11 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-05-11 · Conversion · Acquired 1,455,726 · Balance 1,740,050 F4: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F2: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 1,137,516 |
Reported balance
After 2026-05-11 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2026-05-11 · Conversion · Acquired 872,770 · Balance 1,137,516 F4: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F3: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 2,006,716 |
Reported balance
After 2026-05-11 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2026-05-11 · Purchase · Acquired 266,666 · Balance 2,006,716 F2: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 1,404,183 |
Reported balance
After 2026-05-11 transaction · row 6
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 6 · 2026-05-11 · Purchase · Acquired 266,667 · Balance 1,404,183 F3: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any. |
| Convertible NotesSEC Table II · derivative / convertible security | IndirectSee Footnote | 3,411,892.25 |
Reported balance
After 2026-01-30 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-01-30 · Grant · Acquired 3,411,892.25 · Balance 3,411,892.25 F1: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F5: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a). F2: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. |
| Convertible NotesSEC Table II · derivative / convertible security | IndirectSee Footnote | 3,176,955.03 |
Reported balance
After 2026-01-30 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-01-30 · Grant · Acquired 3,176,955.03 · Balance 3,176,955.03 F3: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any. F5: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a). F1: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. |
| Convertible NotesSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-05-11 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-05-11 · Conversion · Disposed 3,411,892.25 · Balance 0 F1: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. |
| Convertible NotesSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-05-11 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-05-11 · Conversion · Disposed 3,176,955.03 · Balance 0 F1: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F3: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $15.00 · Expires 2036-05-07 | Direct | 31,520 |
Reported balance
After 2026-05-07 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-05-07 · Grant · Acquired 31,520 · Balance 31,520 F6: The stock option will vest in three substantially equal installments on the first three anniversaries of the grant date. |
| Series E-2 Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-05-11 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-05-11 · Conversion · Disposed 3,930,352 · Balance 0 F4: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F2: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. |
| Series F Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-05-11 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2026-05-11 · Conversion · Disposed 1,139,946 · Balance 0 F4: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F2: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. |
| Series F Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2026-05-11 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2026-05-11 · Conversion · Disposed 3,039,860 · Balance 0 F4: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F3: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.
F2: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any.
F3: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any.
F4: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms.
F5: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a).
F6: The stock option will vest in three substantially equal installments on the first three anniversaries of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionSeries F Preferred Stock · Derivative | 3,039,860 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · derivative · entry 14 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 872,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F4 · price: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F4 · derivative.exercise_date: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F4 · derivative.expiration_date: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F3 · ownership.nature: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionSeries F Preferred Stock · Derivative | 1,139,946 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · derivative · entry 13 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 327,288 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F4 · price: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F4 · derivative.exercise_date: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F4 · derivative.expiration_date: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F2 · ownership.nature: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionSeries E-2 Preferred Stock · Derivative | 3,930,352 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · derivative · entry 12 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 1,128,438 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F4 · price: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F4 · derivative.exercise_date: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F4 · derivative.expiration_date: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F2 · ownership.nature: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionConvertible Notes · Derivative | 3,176,955.03 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · derivative · entry 11 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 264,746 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F1 · price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F1 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F1 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F3 · ownership.nature: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionConvertible Notes · Derivative | 3,411,892.25 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · derivative · entry 10 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 284,324 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F1 · price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F1 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F1 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2 · ownership.nature: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | PurchaseCommon Stock | 266,667 | $15.00 | $4,000,005.00 |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · nonDerivative · entry 6 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,404,183 F3 · ownership.nature: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | PurchaseCommon Stock | 266,666 | $15.00 | $3,999,990.00 |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · nonDerivative · entry 5 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,006,716 F2 · ownership.nature: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionCommon Stock | 872,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · nonDerivative · entry 4 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,137,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F3 · ownership.nature: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionCommon Stock | 1,455,726 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · nonDerivative · entry 3 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,740,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. F2 · ownership.nature: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionCommon Stock | 264,746 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · nonDerivative · entry 2 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 264,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F3 · ownership.nature: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionCommon Stock | 284,324 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · nonDerivative · entry 1 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 284,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2 · ownership.nature: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. Read SEC document |
| May 07, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | GrantStock Option · Derivative | 31,520 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · derivative · entry 9 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,520 Underlying: Common Stock · 31,520 shares Expires 2036-05-07 F6 · derivative.exercise_date: The stock option will vest in three substantially equal installments on the first three anniversaries of the grant date. Read SEC document |
| January 30, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | GrantConvertible Notes · Derivative | 3,176,955.03 | $3,176,955.03 | $10,093,043,262,642.30 |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · derivative · entry 8 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,176,955.03 Underlying: Common Stock · 264,746 shares Expires not disclosed F3 · derivative.exercise_price: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any. F5 · date: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a). F1 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F1 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F3 · ownership.nature: The securities are held by Osage University Partners IV, LP ("OUP IV"). Osage University GP IV, LLC ("OUP IV GP") is the general partner of OUP IV. The Reporting Person is a manager of OUP IV GP and may be deemed to share voting and dispositive power over the shares held by OUP IV. Each of OUP IV GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP IV, except to the extent of their pecuniary interests therein, if any. Read SEC document |
| January 30, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | GrantConvertible Notes · Derivative | 3,411,892.25 | $3,411,892.25 | $11,641,008,725,610.06 |
DisclosureSEC source: 0001628280-26-033811 · wk-form4_1778549813.xml · derivative · entry 7 HARRINGTON WILLIAM T · CIK 0001256742 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,411,892.25 Underlying: Common Stock · 284,324 shares Expires not disclosed F1 · derivative.exercise_price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F5 · date: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a). F1 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F1 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2 · ownership.nature: The securities are held by Osage University Partners III, LP ("OUP III"). Osage University GP III, LLC ("OUP III GP") is the general partner of OUP III. The Reporting Person is a manager of OUP III GP and may be deemed to share voting and dispositive power over the shares held by OUP III. Each of OUP III GP and the Reporting Person disclaims beneficial ownership over the securities held by OUP III, except to the extent of their pecuniary interests therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.